Batoclimab, a new antibody aimed at the IL-15 receptor, is gaining attention as a valuable clinical option for individuals suffering from difficult-to-treat ulcerative colitis who have responded adequately to existing https://batoclimab497832.veronicablog.com/61289294/batoclimab-a-exciting-new-therapy-for-ulcerative-colitis